about us
With a scientific foundation built upon collaboration with three renowned institutions – CIBER, Fundación Jiménez Díaz, and CIEMAT – KIJI Tx is delivering a new era of IPSC-MSC engineered cell therapy for the treatment of broad range of inflammatory diseases. These professionalized, engineered MSCs have strong preclinical data and the potential to finally fulfil the long-standing promise of MSCs. Our international team of experienced professionals is committed to bringing these innovative therapies to patients in need.
leadership
Our COLLABORATORS
our investors
science
FIRST PRODUCT KJ01
Why do we need a paradigm for MSC :
- MSC have unfulfilled efficacy
- MSC manufacturing has limitations
We are developing gene engineered iPSC-MSCs with a superior demonstrated efficacy and improved manufacturing, consistency, and flexibility.
Our first products are IPSC-MSCS transduced with IL10 and CXCR4. Strong preclinical data show an improved efficacy through synergistic immunomodulation (IL10) and homing (CXCR4).
In addition, IPSC source offers the consistency needed to guarantee a quality manufacturing of the cells.
PIPELINE / PLATFORM
media
LATEST NEWS
LATEST MATERIAL
LATEST EVENT
JOIN US
Thank you for your interest in joining our team. While there are no current open positions, we are always on the lookout for talented individuals to join us in the future. Please feel free to submit your resume and cover letter to contact@kiji-tx.com so that we may keep you in mind for any upcoming opportunities.
CONTACT
